Health3 days ago
FDA Proposes Streamlined Path for Cheaper Biologic Drugs
The Food and Drug Administration (FDA) has unveiled a significant initiative aimed at simplifying the approval process for biosimilars, which are cheaper alternatives to biologic drugs....
